USANA Health Sciences Inc (USNA) stock
USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.22−0.35 (-2.58%)
Close on Nov 18, 2026Market cap $244.26MP/E –Yield –
USANA Health Sciences net income
Net income is the profit left for shareholders after every expense, interest and tax.
USANA Health Sciences's net income for the twelve months ending Jul 4, 2026 was -$22.16M, down 165.0% year over year. For fiscal 2025 it was $10.76M, down 74.4% from the year before. Over ten years it grew -19.5% a year on average. The highest annual figure on record is $126.22M in fiscal 2018.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $10.76M | -74.4% |
| FY2024 | Dec 28, 2024 | $42.03M | -34.1% |
| FY2023 | Dec 30, 2023 | $63.79M | -8.0% |
| FY2022 | Dec 31, 2022 | $69.35M | -40.5% |
| FY2021 | Jan 1, 2022 | $116.51M | -6.5% |
| FY2020 | Jan 2, 2021 | $124.66M | +24.0% |
| FY2019 | Dec 28, 2019 | $100.53M | -20.4% |
| FY2018 | Dec 29, 2018 | $126.22M | +101.8% |
| FY2017 | Dec 30, 2017 | $62.54M | -37.5% |
| FY2016 | Dec 31, 2016 | $100.04M | +5.7% |
| FY2015 | Jan 2, 2016 | $94.67M | +23.5% |
| FY2014 | Jan 3, 2015 | $76.64M | -3.0% |
| FY2013 | Dec 28, 2013 | $79.02M | +19.0% |
| FY2012 | Dec 29, 2012 | $66.43M | +30.9% |
| FY2011 | Dec 31, 2011 | $50.75M | +11.2% |
| FY2010 | Jan 1, 2011 | $45.65M | +36.0% |
| FY2009 | Jan 2, 2010 | $33.56M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 4, 2026 | -$21.38M | -321.5% |
| Q1 FY2026 | Apr 4, 2026 | $7.52M | -20.1% |
| Q4 FY2025 | Jan 3, 2026 | -$1.78M | -139.9% |
| Q3 FY2025 | Sep 27, 2025 | -$6.52M | -161.5% |
| Q2 FY2025 | Jun 28, 2025 | $9.66M | -7.4% |
| Q1 FY2025 | Mar 29, 2025 | $9.40M | -43.1% |
| Q4 FY2024 | Dec 28, 2024 | $4.45M | -73.4% |
| Q3 FY2024 | Sep 28, 2024 | $10.61M | -6.5% |
| Q2 FY2024 | Jun 29, 2024 | $10.43M | -39.7% |
| Q1 FY2024 | Mar 30, 2024 | $16.54M | -10.0% |
| Q4 FY2023 | Dec 30, 2023 | $16.77M | +31.0% |
| Q3 FY2023 | Sep 30, 2023 | $11.35M | -24.0% |
| Q2 FY2023 | Jul 1, 2023 | $17.29M | -9.7% |
| Q1 FY2023 | Apr 1, 2023 | $18.38M | -18.2% |
| Q4 FY2022 | Dec 31, 2022 | $12.80M | -37.0% |
| Q3 FY2022 | Oct 1, 2022 | $14.93M | -45.4% |
| Q2 FY2022 | Jul 2, 2022 | $19.16M | -49.9% |
| Q1 FY2022 | Apr 2, 2022 | $22.47M | -26.6% |
| Q4 FY2021 | Jan 1, 2022 | $20.32M | -48.7% |
| Q3 FY2021 | Oct 2, 2021 | $27.33M | -10.4% |
| Q2 FY2021 | Jul 3, 2021 | $38.23M | +36.7% |
| Q1 FY2021 | Apr 3, 2021 | $30.62M | +15.3% |
| Q4 FY2020 | Jan 2, 2021 | $39.63M | +28.9% |
| Q3 FY2020 | Sep 26, 2020 | $30.51M | +25.9% |
| Q2 FY2020 | Jun 27, 2020 | $27.98M | +30.9% |
| Q1 FY2020 | Mar 28, 2020 | $26.55M | +9.8% |
| Q4 FY2019 | Dec 28, 2019 | $30.75M | -4.9% |
| Q3 FY2019 | Sep 28, 2019 | $24.22M | -22.0% |
| Q2 FY2019 | Jun 29, 2019 | $21.38M | -37.0% |
| Q1 FY2019 | Mar 30, 2019 | $24.17M | -16.5% |
| Q4 FY2018 | Dec 29, 2018 | $32.33M | – |
| Q3 FY2018 | Sep 29, 2018 | $31.04M | +30.6% |
| Q2 FY2018 | Jun 30, 2018 | $33.91M | +45.8% |
| Q1 FY2018 | Mar 31, 2018 | $28.95M | +35.5% |
| Q4 FY2017 | Dec 30, 2017 | -$5.85M | -126.7% |
| Q3 FY2017 | Sep 30, 2017 | $23.77M | -21.0% |
| Q2 FY2017 | Jul 1, 2017 | $23.26M | – |
| Q1 FY2017 | Apr 1, 2017 | $21.36M | – |
| Q4 FY2016 | Dec 31, 2016 | $21.88M | – |
| Q3 FY2016 | Oct 1, 2016 | $30.10M | – |
See a number that looks wrong?